258 related articles for article (PubMed ID: 12593999)
1. Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy.
Shobokshi A; Shaarawy M
J Soc Gynecol Investig; 2003 Feb; 10(2):99-104. PubMed ID: 12593999
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.
Rouzi AA; Ardawi MS
Fertil Steril; 2006 Feb; 85(2):428-35. PubMed ID: 16595222
[TBL] [Abstract][Full Text] [Related]
3. [Effect of rosiglitazone on insulin resistance and hyperandrogenism in polycystic ovary syndrome].
Zheng Z; Li M; Lin Y; Ma Y
Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):271-3. PubMed ID: 12133398
[TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone as treatment for clomiphene citrate-resistant polycystic ovary syndrome: factors associated with clinical response.
Shokeir T; El-Kannishy G
J Womens Health (Larchmt); 2008 Nov; 17(9):1445-52. PubMed ID: 18973428
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight/obese women with polycystic ovary syndrome.
Mohsen IA
Gynecol Endocrinol; 2012 Apr; 28(4):269-72. PubMed ID: 21970545
[TBL] [Abstract][Full Text] [Related]
6. Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome.
Ghazeeri G; Kutteh WH; Bryer-Ash M; Haas D; Ke RW
Fertil Steril; 2003 Mar; 79(3):562-6. PubMed ID: 12620440
[TBL] [Abstract][Full Text] [Related]
7. Effect of rosiglitazone on endocrine, metabolism and ovulatory performance in patients with polycystic ovary syndrome and insulin resistance.
Lv L; Liu Y
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(5):480-2. PubMed ID: 15641698
[TBL] [Abstract][Full Text] [Related]
8. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
9. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
Zaidi J; Jacobs H; Campbell S; Tan SL
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
[TBL] [Abstract][Full Text] [Related]
10. Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome.
de Leo V; la Marca A; Morgante G; Ciotta L; Mencaglia L; Cianci A; Petraglia F
Hum Reprod; 2000 Nov; 15(11):2302-5. PubMed ID: 11056123
[TBL] [Abstract][Full Text] [Related]
11. Short-term metformin treatment for clomiphene citrate-resistant women with polycystic ovary syndrome.
Kazerooni T; Ghaffarpasand F; Kazerooni Y; Kazerooni M; Setoodeh S
Int J Gynaecol Obstet; 2009 Oct; 107(1):50-3. PubMed ID: 19552904
[TBL] [Abstract][Full Text] [Related]
12. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome.
Belli SH; Graffigna MN; Oneto A; Otero P; Schurman L; Levalle OA
Fertil Steril; 2004 Mar; 81(3):624-9. PubMed ID: 15037412
[TBL] [Abstract][Full Text] [Related]
13. Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V; Nagamani M
J Clin Endocrinol Metab; 2005 Jan; 90(1):60-5. PubMed ID: 15483106
[TBL] [Abstract][Full Text] [Related]
14. Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy.
Berker B; Emral R; Demirel C; Corapcioglu D; Unlu C; Kose K
Gynecol Endocrinol; 2004 Sep; 19(3):125-33. PubMed ID: 15697073
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
16. Endocrine changes after laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovarian syndrome.
Al-Ojaimi EH
Saudi Med J; 2004 Aug; 25(8):1032-9. PubMed ID: 15322594
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome.
Sönmez AS; Yasar L; Savan K; Koç S; Ozcan J; Toklar A; Yazicioğu F; Akgün A; Sut N
Hum Reprod; 2005 Jan; 20(1):175-9. PubMed ID: 15513975
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome.
Kettel LM; Roseff SJ; Berga SL; Mortola JF; Yen SS
Fertil Steril; 1993 Mar; 59(3):532-8. PubMed ID: 8458453
[TBL] [Abstract][Full Text] [Related]
20. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
